
Publikationen von A. Schuld
Alle Typen
Zeitschriftenartikel (63)
1.
Zeitschriftenartikel
135 (1-3), S. 123 - 127 (2012)
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research 2.
Zeitschriftenartikel
35 (2), S. 231 - 236 (2012)
Glucose Tolerance in Patients with Narcolepsy. Sleep 3.
Zeitschriftenartikel
27 (Suppl. 1), 0-27 (2012)
Sleep propensity at daytime as assessed by multiple sleep latency tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. European Psychiatry 4.
Zeitschriftenartikel
45 (9), S. 1223 - 1228 (2011)
The stress hormone system in various sleep disorders. Journal of Psychiatric Research 5.
Zeitschriftenartikel
34 (1), S. 118 - 128 (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 6.
Zeitschriftenartikel
27 (6), S. 662 - 666 (2007)
Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology 7.
Zeitschriftenartikel
40 (5), S. 241 - 241 (2007)
Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry 8.
Zeitschriftenartikel
2, S. 293 - 302 (2007)
Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 9.
Zeitschriftenartikel
60, S. 882 - 888 (2006)
Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis. Biological Psychiatry 10.
Zeitschriftenartikel
29 (1), S. 170 - 170 (2006)
Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care 11.
Zeitschriftenartikel
114, S. 322 - 328 (2006)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 12.
Zeitschriftenartikel
38 (5), S. 230 - 230 (2005)
Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 13.
Zeitschriftenartikel
38 (5), S. 249 - 249 (2005)
Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry 14.
Zeitschriftenartikel
38 (5), S. 248 - 249 (2005)
Does antidepressant therapy improve glucose metabolism? Pharmacopsychiatry 15.
Zeitschriftenartikel
38 (5), S. 264 - 264 (2005)
Efficacy of electroconvulsive therapy for depressive disorders in a Bavarian district hospital. Pharmacopsychiatry 16.
Zeitschriftenartikel
38 (5), S. 270 - 270 (2005)
Cognitive-behavioral therapy of patients with pure and comorbid panic disorder in a hospital setting - a comparison of therapy response. Pharmacopsychiatry 17.
Zeitschriftenartikel
38 (5), S. 270 - 270 (2005)
Metabolic abnormalities in patients with chronic psychiatric disorders receiving long-term psychopharmacological treatment. Pharmacopsychiatry 18.
Zeitschriftenartikel
102 (31-32), S. A 2172 - A 2177 (2005)
Gewichtszunahme unter Psychopharmakotherapie. Deutsches Ärzteblatt 19.
Zeitschriftenartikel
39, S. 35 - 42 (2005)
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. Journal of Psychiatric Research 20.
Zeitschriftenartikel
179 (2), S. 447 - 451 (2005)
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology